AAIC 2024 Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

AAIC 2024 Insights: Potential of Targeting the Alpha-1 Adrenergic Receptor and Phosphoglycerate Kinase 1 With Terazosin to Treat Alzheimer’s Disease Using a Transgenic Rat Model

52 views
August 14, 2024
Comments 0
Login to view comments. Click here to Login